Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update

Go back to Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update

BioNano Genomics, Inc. (BNGO) Reports Q3 Revs of $2.2M

November 12, 2020 4:03 PM EST

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q3 revenue of $2.2 million versus the consensus estimate of $2.07 million.

We believe key events this quarter have set us up for continued growth and success, said Erik Holmlin, Ph.D., CEO of Bionano. Yesterday, in the largest Saphyr... More